Antibody against carcinoembryonic antigen (cea)

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/13 (2006.01) A61K 39/395 (2006.01) A61K 47/48 (2006.01) A61K 49/00 (2006.01) A61K 51/10 (2006.01) C07K 16/00 (2006.01) C07K 16/06 (2006.01) C07K 16/30 (2006.01) C07K 16/46 (2006.01)

Patent

CA 2177584

The invention provides an antibody specific for carcinoembryonic antigen (CEA) which has a dissociation constant (Kd) of less than 5.0 nM for said antigen. The antibody is generally a single chain Fv (scFv) antibody. The antibody was initially obtained by screening a bacteriophage library for phage expressing high affinity CEA antibody. The antibody is useful for diagnosis and therapeutic treatment of colorectal tumours.

L'invention se rapporte à un anticorps spécifique de l'antigène carcino-embryonnaire (CEA) qui présente une constante de dissociation (Kd) dudit antigène inférieure à 5,0 nM. Cet anticorps est généralement un anticorps à chaîne simple Fv (scFv). On a initialement obtenu cet anticorps par criblage d'une bibliothèque de bactériophages afin qu'un phage exprime un anticorps présentant une affinité élevée à l'égard de l'antigène carcino-embryonnaire (CEA). Cet anticorps est utile dans le diagnostic et le traitement thérapeutique des tumeurs colo-rectales.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Antibody against carcinoembryonic antigen (cea) does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antibody against carcinoembryonic antigen (cea), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibody against carcinoembryonic antigen (cea) will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1430309

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.